Skip to content

Study of Herbal medicine in lowering blood pressure in comparison with standard medicine

Clinical assessment of treatment efficacy of herbal formulation in reducing hypertension and to compare with standard medication.

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/03/050643
Enrollment
120
Registered
2023-03-13
Start date
Unknown
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I10- Essential (primary) hypertension Health Condition 2: I10- Essential (primary) hypertension

Interventions

None listed

Sponsors

National Innovation Foundation India
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: • Age group 18-70 years , Either Sex • Essential hypertension : Mild (Systolic BP- 140 to 159mm Hg and /or Diastolic BP- 90 to 99 mmHg) and Moderate (Systolic 160- 179mm of Hg / or Diastolic BP- 100-109)

Exclusion criteria

Exclusion criteria: 1. History of coronary artery disease, myocardial infarction, stroke, transient ischemic attack, any revascularization procedure, congestive heart failure, or hemodynamically significant carotid or peripheral arterial disease 2. Pregnant / Breast feeding women. 3. Women having hormonal contraception or having no effective birth control measure. 4. Diabetes mellitus type I and II 5. As per the opinion of investigator ,any other Surgical /medical illness not mentioned in the protocol - which may place patients at high risk due to their participation in the study OR may lead to their noncompliance to the protocol. 6. Use of other concomitant medications â?? adrenergic drugs or steroids that may affect blood pressure. 7. Hypersensitivity to any of the test drug 8. Patients with kidney or liver disease

Design outcomes

Primary

MeasureTime frame
LOWERING OF BLOOD PRESSURETimepoint: â?¢ Follow up: Every 7th day for upto 1 month and every 15th day after one month the patients will be observed for subjective and objective parameters will be recorded.

Secondary

MeasureTime frame
Blood pressure in normal limits is sustainedTimepoint: â?¢ Follow up: Every 7th day for upto 1 month and every 15th day after one month the patients will be observed for subjective and objective parameters will be recorded.

Countries

India

Contacts

Public ContactDr Dattatraya Lakshman Shinde

Bharati Vidyapeeth Deemed University,College of Ayurved & Hospital,Pune

dshinde249@gmail.com9890111954

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026